1-1 of 1
Hanbin Li, PhD
Close
Sort by
Journal Articles

Exposure-Response Analysis For Pacritinib (SB1518), a Novel Oral JAK2/FLT3 Inhibitor, In Patients With Myelofibrosis

Suliman Al-Fayoumi, PhD, MBA, Lixia Wang, PhD, Hanbin Li, PhD, Russ Wada, PhD, James P. Dean, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4080.
https://doi.org/10.1182/blood.V122.21.4080.4080
Published: 2013